How mutations in DNMT3A affect blood cell development and disease progression
Official title: Integration of HSC Stress Responses and Disease Progression by DNMT3A Mutations
Funded at Northwestern University · NIH-11103614 · Data updated 2026-11-12
This study is looking at how certain changes in a gene called DNMT3A might help blood stem cells survive better during long-term inflammation, which could lead to blood-related illnesses, and it's being led by Dr. Christine Zhang, who wants to learn more about blood health and genetics while working with top experts in the field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | July 1, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $248,998 |
| NIH project number | 4R00HL165103-03 |
| Project ID | NIH-11103614 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with known DNMT3A mutations or those experiencing chronic inflammation related to blood disorders.
✕Less likely to help
Patients without blood diseases or those not affected by DNMT3A mutations may not benefit from this research.
What this research studies
This research investigates the role of DNMT3A mutations in hematopoietic stem cells (HSC) and how these mutations may provide a fitness advantage during chronic inflammation, potentially leading to blood diseases. The principal investigator, Dr. Christine Zhang, aims to enhance her expertise in hematology and epigenetics while employing advanced techniques to analyze how these genetic changes impact blood cell formation and function. By collaborating with leading experts in the field, the research seeks to uncover the mechanisms behind defective hematopoiesis and its implications for disease progression.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with blood diseases linked to DNMT3A mutations.
How similar studies have gone: Previous research has shown promising results in understanding the role of genetic mutations in blood diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Northwestern University
Chicago, United States Active
Researchers
- Principal investigator: Zhang, Christine R — Northwestern University
- Study coordinator: Zhang, Christine R
Related research
Other NIH-funded projects on the same topics.
-
Understanding how language and social communication work in FMR1-related autism risks
A small, patient-friendly study looks at why people with FMR1 gene changes may have pragmatic language difficulties, which are common in autism and related conditions.
-
Transformative patient navigation interventions for cancer care in diverse communities
A nationwide cancer center is testing new, community-driven ways to help people with cancer navigate care and information, especially where access is challenging.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Point-of-care AQP4 antibody test to diagnose NMO in low-resource settings
A low-cost, mail-in dried-blood-spot test is being studied to diagnose neuromyelitis optica in people who live far from big labs or in low-income countries.
-
Supercomputer models to understand how human motor signals reach muscles
A computer-based effort uses human motoneuron models to figure out the exact mix of inputs that control muscle activity.
-
Negotiation training to help Alzheimer’s caregivers communicate with care teams
A program called NegotiAge helps families caring for people with Alzheimer’s disease learn better negotiation skills to talk with doctors, insurers, and other caregivers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.